Overview

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

Status:
Not yet recruiting

Trial end date:
2024-08-30

Target enrollment:

Participant gender:

Summary

This study is being conducted to explore the efficacy and safety of camrelizumab combined with SHR1020 in the treatment of advanced melanoma.

Phase:

Phase 2

Details

Lead Sponsor:

Beijing Cancer Hospital